Lifestyle Features

Online registry highlights Utah's haunted 'real estate'

VideoAndrew Adams, KSL  |  Updated Oct. 31 - 4:11 p.m.  |  Save Story

Kris Bowen acknowledged that sometimes a property's spooky secrets are something to be celebrated, which is why he created "Utah's Real Haunted Houses: The Registry."

Red Cross urges Utahns to check smoke alarms as daylight saving time ends

VideoEmma Benson, KSL  |  Updated Oct. 31 - 2:21 p.m.  |  Save Story

The American Red Cross is reminding Utahns to check their smoke alarms as daylight saving time ends this weekend and the risk of home fires increases during the colder months.

Halloween through the years: A look back at Utah's spooky season traditions

VideoShelby Lofton, KSL  |  Updated Oct. 31 - 11:30 a.m.  |  Save Story

From trick-or-treating and costume parades to candy safety and haunted graveyards, KSL archive footage reveals how Halloween traditions in Utah have evolved over the decades.

Utah single mom turns birthday party hobby into thriving events business with reality TV clients

VideoTamara Vaifanua, KSL  |  Updated Oct. 30 - 9:23 p.m.  |  Save Story

Kenzie Bates never thought anyone would pay her to do what she loves. Now her client list includes stars of reality TV.

Daybreak Halloween map helps families plan trick-or-treat routes

VideoAnnette Campbell, KSL  |  Updated Oct. 30 - 5:58 p.m.  |  Save Story

Families looking for the best Halloween displays in Daybreak can now use an online map and mobile app to plan their trick-or-treating routes and discover participating homes.

Farmington man's 30-year pumpkin carving hobby becomes Halloween tradition

VideoMadi Vollmer, KSL  |  Updated Oct. 30 - 3:04 p.m.  |  Save Story

One Farmington man has spent three decades creating an elaborate pumpkin display, welcoming visitors to enjoy his work and support a local food pantry.

How stencils make an easier job of last-minute pumpkin carving

Staff  |  Posted Oct. 29 - 9:43 p.m.  |  Save Story

Using stencils to build Halloween pumpkins can really up your porch game — just trace, and, carefully, cut.

Hotel Vernal Haunt to end after Halloween

VideoAndrew Adams, KSL  |  Posted Oct. 29 - 9:54 a.m.  |  Save Story

Halloween night is always important for haunted attractions, but this year it will mean more to those who run the Hotel Vernal Haunt, as it will close at the end of the season.

Pennsylvania teen's birthday wish for more friends comes true

Wakisha Bailey  |  Updated Oct. 28 - 7:15 p.m.  |  Save Story

The long afterlife of a one-use Halloween costume

Margaret Darby, Deseret News  |  Posted Oct. 28 - 3:04 p.m.  |  Save Story

Attending local Halloween swaps or exchanging costumes with friends and family are two ways to reduce waste this season, but where and how do you find them? Read here.

Lilly's retatrutide outshines Ozempic on weight loss, blood sugar control in trial

Sriparna Roy, Reuters  |  Updated Oct. 28 - 10:07 a.m.  |  Save Story

Eli Lilly said on Wednesday its experimental next-generation obesity drug, retatrutide, outperformed Novo ​Nordisk's Ozempic on blood sugar control and delivered more than double the weight loss in a diabetes study.

Supplements brand Rho Nutrition explores sale, sources say

Abigail Summerville, Reuters  |  Updated Oct. 28 - 9:56 a.m.  |  Save Story

Rho Nutrition, a maker of ​liquid supplements and vitamins, is exploring a sale that could value the company at over $500 million, ‌according to people familiar with the matter.

Geron discontinues late-stage trial of blood cancer drug, shares plunge

Christy Santhosh, Reuters  |  Updated Oct. 28 - 9:08 a.m.  |  Save Story

Geron said on Wednesday it would halt a late-stage ​trial of its blood cancer treatment, marking a setback for the company's only commercial product, sending its shares plunging ‌20% in early trading.

GSK pipeline doubts, vaccine underperformance overshadow sales beat

Pushkala Aripaka, Reuters  |  Updated Oct. 28 - 9:05 a.m.  |  Save Story

GSK investors punished the British drugmaker on Wednesday despite a third-quarter sales and profit beat, focusing instead on questions over its ​drug pipeline and weak sales of vaccines, including its shingles shot Shingrix.

Biogen tops quarterly estimates on rare-disease drug strength

Christy Santhosh, Reuters  |  Updated Oct. 28 - 8:29 a.m.  |  Save Story

Biogen beat Wall Street estimates for third-quarter results on Wednesday, as robust ​demand for its rare-disease and Alzheimer's treatments helped offset declines in its under-pressure multiple sclerosis franchise.

A US cruise ship suspends a global voyage in Asia due to fuel costs, stranding 200 passengers

Sopheng Cheang, Associated Press  |  Updated Oct. 28 - 8:23 a.m.  |  Save Story

A U.S. cruise ship on a global voyage that touted its cabins as floating homes suspended its three-year voyage in Cambodia due to fuel costs, forcing hundreds of passengers to disembark.

Cooper Companies CEO White steps down

Siddhi Mahatole, Reuters  |  Updated Oct. 27 - 4:32 p.m.  |  Save Story

Cooper Companies said on Tuesday CEO Al White had ​stepped down, effective immediately, and board member Walt Rosebrough was elected executive chair as the medical device maker begins ‌its search for a new CEO.

Artiva to discontinue cell therapy after two patient deaths, cut workforce by 94%

Reuters  |  Updated Oct. 27 - 3:02 p.m.  |  Save Story

Artiva Biotherapeutics said on Tuesday it would halt the development ​of an experimental cell therapy for certain autoimmune conditions — its lead candidate — after two patient deaths, ‌sending its shares slumping 32%.

Eli Lilly international business chief Jonsson to retire; Yuffa to head global markets unit

Reuters  |  Updated Oct. 27 - 2:47 p.m.  |  Save Story

Eli Lilly said on Tuesday that Patrik Jonsson, executive vice ​president and president of its international business, will retire at the end of 2026 after a 36-year career ‌at the US drugmaker.